ecrin-mdr-crcClinical2002Lung CancerEsophageal NeoplasmsColorectal CancerGastric CancerEsophageal CancerColorectal NeoplasmsAnal CancerStomach NeoplasmsAnus NeoplasmsLung CancerEsophageal NeoplasmsColorectal CancerGastric CancerEsophageal CancerColorectal NeoplasmsAnal CancerStomach NeoplasmsAnus NeoplasmsObservationalhttps://newmdr.ecrin.org/Study/2042174United States11SurveyQuestionnaireCytokinesChemoradiation TherapyECRIN MDRCompletedfalseAssessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer PatientsPrimary Objectives: * To determine the feasibility of a study that would describe changes of certain circulating inflammatory cytokines (interleukin-1, 6, 8, 10, 12, and tumor necrosis factor-alpha [TNF] and symptoms related to chemoradiation therapy (pre-therapy, during therapy and up to 3 months post-therapy) among patients with lung, esophageal, gastric, colorectal and anal cancer. * To determine the feasibility of studying neurocognitive function in patients with non-small cell lung cancer (NSCLC) at presentation and during chemoradiation therapy to determine the prevalence, severity, and pattern of cognitive symptoms.2002-11-152042174NCT00502502